GLP-1 drug for early stage type 1 diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a medicine called a GLP-1 receptor agonist (like Ozempic) to see if it can help people with very early type 1 diabetes (stage 1) keep their insulin-making cells working longer. You may be a good fit if you have stage 1 type 1 diabetes and haven't needed insulin yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage 1 type 1 diabetes (autoantibodies positive but normal blood sugar).
- You have not had bariatric surgery.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have a personal or family history of medullary thyroid cancer or certain other cancers.
- You have not had severe low blood sugar in the last 3 months.
- Your BMI is not too low (adults above 18.5, kids above 5th percentile).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of medicine that helps control blood sugar and appetite) can improve metabolic health in people with early type 1 diabetes. It may be an option if you have already taken teplizumab to delay the disease or were recently diagnosed with type 1 diabetes.
This study looks at how blood sugar control and a class of drugs called GLP-1 agonists (like Ozempic) affect insulin-making cells in people with type 1 or type 2 diabetes who use insulin.
This trial tests if a new form of semaglutide works as well as the approved drug Ozempic for lowering blood sugar. It's for adults with type 2 diabetes who are already taking metformin and need better sugar control.
This study tests two different medicines (empagliflozin or semaglutide) added to your usual insulin to see if they help with blood sugar control and weight loss in people with type 1 diabetes who are overweight or have obesity. It may be a good fit if your diabetes is not well controlled with insulin injections alone.
This study tests if a type 2 diabetes medication called a GLP-1 receptor agonist (like Ozempic) is safe and effective for people on dialysis. It may help manage blood sugar and improve health outcomes for those with kidney failure.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Hear when a new Stage 1 Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.